$2.070
-0.086 (-4.17%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
LTRN Prediction & Forecast by Similar Chart Analysis
Alphio's LTRN stock price prediction model matches the current Lantern Pharma Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.07 (+0.01%). The 1-week path is $2.05 (-0.81%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Lantern Pharma Inc Stock?
Lantern Pharma Inc is not a good buy right now due to its significant financial losses and poor technical indicators. The current price is $2.07, and the RSI is at an extremely low 18.641, indicating oversold conditions but also a lack of buying momentum. Additionally, the company has reported a net loss of $7.1 million in Q2 2026, which raises concerns about its financial health and future profitability. The main risk is the declining cash position, with only $7.4 million in cash and equivalents, which may not sustain operations for long without further financing.
LTRN stock price ended at $2.07 on Friday, after losing -4.17%
Lantern Pharma Inc (LTRN) last closed at $2.07, losing -4.17%. These facts feed the 1-day and 1-week LTRN price prediction above.
Forecast Drivers
Lantern Pharma Inc (LTRN) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches LTRN, ranked by similarity.
Seasonality analysis for LTRN
Historically the probability of a positive August return for LTRN is 49.21%. January offers the highest probability of a positive month at 75.41%, while November is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for LTRN
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $4.75 | $4.82 | $5.81 | +132.75% |
| Sep 2026 | $3.58 | $4.55 | $4.98 | +119.69% |
| Oct 2026 | $4.05 | $4.82 | $5.16 | +132.75% |
| Nov 2026 | $3.38 | $3.58 | $3.82 | +73.00% |
| Dec 2026 | $3.45 | $4.23 | $4.41 | +104.29% |
In 2026, Lantern Pharma Inc (LTRN) is projected to range from $3.38 to $5.81.
Lantern Pharma Inc 2026 monthly forecast
In Aug 2026, Lantern Pharma Inc is projected to average $4.82, with a low of $4.75 and high of $5.81.
In Sep 2026, Lantern Pharma Inc is projected to average $4.55, with a low of $3.58 and high of $4.98.
In Oct 2026, Lantern Pharma Inc is projected to average $4.82, with a low of $4.05 and high of $5.16.
In Nov 2026, Lantern Pharma Inc is projected to average $3.58, with a low of $3.38 and high of $3.82.
In Dec 2026, Lantern Pharma Inc is projected to average $4.23, with a low of $3.45 and high of $4.41.
本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。